您的位置: 首页 > 农业专利 > 详情页

b2 bradykinin receptor monoclonal antibody (bkb2r)
专利权人:
DIAMEDICA INC.
发明人:
MARK S. WILLIAMS,MATTHEW L. CHARLES
申请号:
BR112013013674
公开号:
BR112013013674A2
申请日:
2011.12.01
申请国别(地区):
BR
年份:
2016
代理人:
摘要:
The present invention relates generally to anti-bradykinin B2 receptor (BKB2R) antibodies and methods for making and using them. In particular, the anti-BKB2R antibodies having the variable region sequences described herein are useful for altering one or more of BKB2R of and/or GSK-3 signaling pathways for the treatment of diseases, disorders and conditions such as cancer, diabetes, cardiovascular disorders and other conditions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充